The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ness, T. L.
Right arrow Articles by Kunkel, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ness, T. L.
Right arrow Articles by Kunkel, S. L.
The Journal of Immunology, 2003, 171: 3775-3784.
Copyright © 2003 by The American Association of Immunologists

Immunomodulatory Role of CXCR2 During Experimental Septic Peritonitis 1

Traci L. Ness*, Cory M. Hogaboam*, Robert M. Strieter{dagger} and Steven L. Kunkel*,2,3

* Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109; and {dagger} Division of Pulmonary and Critical Care Medicine, University of California School of Medicine, Los Angeles, CA 90024

The loss of CXCR2 expression by neutrophils is a well-described, but poorly understood, consequence of clinical sepsis. To address the potential impact of this CXCR2 deficit during the septic response, we examined the role of CXCR2 in a murine model of septic peritonitis provoked by cecal ligation and puncture (CLP). CLP-induced mouse mortality was significantly attenuated with i.v. or i.p. administration of an affinity-purified murine CXCR2-specific polyclonal Ab. Mouse survival required Ab administration before and every 2 days following CLP. Furthermore, mice deficient in CXCR2 (CXCR2-/-) were significantly protected against CLP-induced mortality compared with control (CXCR2+/+) mice. The anti-CXCR2 Ab treatment delayed, but did not completely inhibit, the recruitment of leukocytes, specifically neutrophils, into the peritoneal cavity. Peritoneal macrophages from anti-CXCR2 Ab-treated mice exhibited markedly increased RNA and protein levels of several key proinflammatory cytokines and chemokines. Specifically, isolated preparations of these cells released ~11-fold more CXCL10 protein compared with peritoneal macrophages from control-treated or naive mice. CXCR2-/- mice had higher resting and CLP-induced levels of peritoneal CXCL10 compared with CXCR2+/+ mice. Administration of a neutralizing, affinity-purified, murine CXCL10-specific polyclonal Ab before CLP in wild-type mice and every 2 days after surgery significantly increased mortality compared with control Ab-treated mice. Anti-CXCL10 treatment in CXCR2-/- mice negated the protective effect associated with the absence of CXCR2. In summary, these data demonstrate that the absence of CXCR2 protects mice from septic injury potentially by delaying inflammatory cell recruitment and enhancing CXCL10 expression in the peritoneum.




This article has been cited by other articles:


Home page
 J. Immunol.Home page
Y. Ishida, T. Hayashi, T. Goto, A. Kimura, S. Akimoto, N. Mukaida, and T. Kondo
Essential Involvement of CX3CR1-Mediated Signals in the Bactericidal Host Defense during Septic Peritonitis
J. Immunol., September 15, 2008; 181(6): 4208 - 4218.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
V. Nomellini, D. E. Faunce, C. R. Gomez, and E. J. Kovacs
An age-associated increase in pulmonary inflammation after burn injury is abrogated by CXCR2 inhibition
J. Leukoc. Biol., June 1, 2008; 83(6): 1493 - 1501.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
W. A. Altemeier, X. Zhu, W. R. Berrington, J. M. Harlan, and W. C. Liles
Fas (CD95) induces macrophage proinflammatory chemokine production via a MyD88-dependent, caspase-independent pathway
J. Leukoc. Biol., September 1, 2007; 82(3): 721 - 728.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M. He, R. Horuk, S. M. Moochhala, and M. Bhatia
Treatment with BX471, a CC chemokine receptor 1 antagonist, attenuates systemic inflammatory response during sepsis
Am J Physiol Gastrointest Liver Physiol, April 1, 2007; 292(4): G1173 - G1180.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. L. Ness, J. L. Ewing, C. M. Hogaboam, and S. L. Kunkel
CCR4 Is a Key Modulator of Innate Immune Responses
J. Immunol., December 1, 2006; 177(11): 7531 - 7539.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
L. Chen, S.-x. Lin, R. Agha-Majzoub, L. Overbergh, C. Mathieu, and L. S. Chan
CCL27 is a critical factor for the development of atopic dermatitis in the keratin-14 IL-4 transgenic mouse model
Int. Immunol., August 1, 2006; 18(8): 1233 - 1242.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
O. Kollmar, C. Scheuer, M. D. Menger, and M. K. Schilling
Macrophage Inflammatory Protein-2 Promotes Angiogenesis, Cell Migration, and Tumor Growth in Hepatic Metastasis
Ann. Surg. Oncol., February 1, 2006; 13(2): 263 - 275.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. L. Ness, K. J. Carpenter, J. L. Ewing, C. J. Gerard, C. M. Hogaboam, and S. L. Kunkel
CCR1 and CC Chemokine Ligand 5 Interactions Exacerbate Innate Immune Responses during Sepsis
J. Immunol., December 1, 2004; 173(11): 6938 - 6948.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.